Reverb Therapeutics
Neal Gordon is a seasoned biotech executive currently serving as Senior Vice President of the Enabling Technology Initiative at Flagship Pioneering and as a Technical Advisory Board Member at ChromaTan, Inc. Additionally, Neal holds the position of Strategic Advisor to the CEO and board at Reverb Therapeutics. With a robust background in biologics consulting from January 2013 to March 2024, experience as Managing Director at BDO USA, LLP from October 2019 to June 2023, and roles including Chief Development Officer at Cobalt Biomedicine and Head of Technical Operations at Epiva Biosciences, Neal has demonstrated expertise in R&D management, operations, and bioprocess development. Neal's educational credentials include a Ph.D. in Biochemical Engineering from the Massachusetts Institute of Technology and a B.Eng. in Chemical Engineering from McGill University.
This person is not in any teams
This person is not in any offices
Reverb Therapeutics
We develop bispecific antibodies that exploit the potential of the natural immune system. Our Amplify•R platform amplifies and redirects endogenous cytokine signaling instead of recombinant cytokines. We avoid issues such as systemic toxicity, immunogenicity and manufacturing concerns.